Meta-Analysis
Copyright ©The Author(s) 2015.
World J Gastroenterol. May 21, 2015; 21(19): 6032-6043
Published online May 21, 2015. doi: 10.3748/wjg.v21.i19.6032
Table 1 Clinical data of included studies
Ref.Duration of follow upLocation, languageComplete resectionCurative resectionEn bloc resectionTotal recurrenceAdverse eventsTotal patients
Kim et al[23], 2009Mean 17.1 ± 9.1 moSouth Korea (English)1/32Bleeding 6/3232
Kang et al[24], 2010Mean 16 moSouth Korea (English)33/6060/600/60Bleeding 1/60 perforation 1/6060
Lee et al[25], 2010Median 13.5 moSouth Korea (English)22/58148/580/16 (3 yr) 0/2 (5 yr)58
Yamamoto et al[26], 2010Japan (English)46/5857/58Bleeding 5/58 perforation 2/5858
Goh et al[27], 2011Mean 19.39 ± 11.2 moSouth Korea (English)10/183/1418
Park et al[28], 2012Mean 41 moSouth Korea, multicenter (2) (English)23/5555
Kamada et al[29], 2012Mean 3.8 yrJapan (English)37/4642/461/462Bleeding 2/46 perforation 2/4646
Okada et al[30], 2012Median 36 moJapan (English)85/103102/103Bleeding 9/101 perforation 1/101103
Park et al[31], 2013Median 24.1 mo (absolute indication group), 30 mo (expanded indication group)South Korea (English)91/116106/116Bleeding 7/116 perforation 6/116116
Choi et al[32], 2013Mean 37.4 moSouth Korea (Korean)66/8272/823/82382
Kim et al[33], 2013Median 34 moSouth Korea, multicenter (6) (English)54/7423/7467/744/74Bleeding 1/74 perforation 3/7474
Abe et al[34], 2013Median 76.4 moJapan (English)88/9762/9796/972/794Bleeding 4/97 perforation 3/97 delayed perforation 1/9797
Chung et al[35], 2014Mean 41.7 ± 22.6 moSouth Korea (Korean)58/7664/769/64Bleeding 4/76 perforation 0/7676
Oka et al[36], 2014Mean 101.9 ± 38.9 moJapan (English)86/9760/97Bleeding 6/97 perforation 1/9797
Table 2 Clinical data of included studies (expanded indication)
Ref.Complete resectionCurative resectionEn bloc resectionTotal recurrenceTotal patientsAdverse events
Kang et al[24], 201017/1818
Lee et al[25], 201011/1717
Yamamoto et al[26], 201046/47146/4747/4747Bleeding 5/47 perforation 2/47
Park et al[28], 201223/5555
Kamada et al[29], 201232/3434
Okada et al[30], 201285/103102/103103
Park et al[31], 201391/116106/116116Bleeding 7/116 perforation 6/116
Choi et al[32], 201366/8272/8282
Kim et al[33], 201323/2923/2925/2929Bleeding 0/29 perforation 2/29
Chung et al[35], 201450/5851/5858Bleeding 4/76 perforation 0/76
Oka et al[36], 201457/6060
Table 3 Clinical data of included studies (expanded indication vs beyond expanded indication)
Ref.Location, languageComplete resection
En bloc resection
Recurrence
EI effectiveEI totalBeyond EI effectiveBeyond EI totalEIBeyond EIEIBeyond EI
Kang et al[24], 2010South Korea (English)1718164218/1842/420/180/42
Lee et al[25], 2010South Korea (English)11171130
Yamamoto et al[26] 2010Japan (English)464761147/4710/11
Kamada et al[29], 2012Japan (English)32347120/341/12
Kim et al[33], 2013South Korea, multicenter (6) (English)2232931450/294/45
Chung et al[35], 2014South Korea (Korean)505881851/5813/18
Oka et al[36], 2014Japan (English)57602937
Table 4 Methodological quality of included studies measured by Newcastle-Ottawa scale
Ref.SelectionComparabilityExposure or outcomeTotal
Kim et al[23], 20094127
Kang et al[24], 20104127
Lee et al[25], 20104228
Yamamoto et al[26], 20104138
Goh et al[27], 20113126
Park et al[28], 20123137
Kamada et al[29], 20124138
Okada et al[30], 2012437
Park et al[31], 20134228
Choi et al[32], 20134239
Kim et al[33], 20134138
Abe et al[34], 20134138
Chung et al[35], 20143238
Oka et al[36], 20143137